To evaluate the role of JMJD6-expressing macrophages in tumor progression, we established two tumor models in WT and Jmjd6+/− mice with subcutaneous injection of LLC lung cancer cells and intravenous injection of B16F10 melanoma cells. Here, JMJD6 is linked to lung cancer.